抗菌薬耐性 ―国家的(および国際的)リスクの高まり

2016.01.31

Antimicrobial resistance — a ‘rising tide’ of national (and international) risk


J. Cole*
*Royal United Services Institute for Defence and Security Studies, UK
Journal of Hospital Infection (2016) 92, 3-4
No Abstract.
サマリー原文(英語)はこちら
監訳者コメント
グローバルな視点に立って耐性菌の課題を突きつけている提言である。テロも怖いが耐性菌も深刻な問題であると指摘している。生命予後ならびに経済的損失についても推計値をもとに解説している。

同カテゴリの記事

2021.01.31

Targeted rapid testing for SARS-CoV-2 in the emergency department is associated with large reductions in uninfected patient exposure time

J.S. Hinson*, R.E. Rothman, K. Carroll, H.H. Mostafa, K. Ghobadi, A. Smith, D. Martinez, K. Shaw-Saliba, E. Klein, S. Levin

*Johns Hopkins University School of Medicine, USA

Journal of Hospital Infection (2021) 107, 35-39

2020.12.31

Does copper treatment of commonly touched surfaces reduce healthcare-acquired infections? A systematic review and meta-analysis
L. Albarqouni*, O. Byambasuren, J. Clark, A.M. Scott, D. Looke, P. Glasziou
*Bond University, Australia
Journal of Hospital Infection (2020) 106, 765-773

2018.02.28

Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO)

2021.07.31
Barriers and enablers to implementing hospital-acquired urinary tract infection prevention strategies: a qualitative study using the Theoretical Domains Framework

O. Fasugba*, E. McInnes, J. Baye, H. Cheng, R. Gordon, S. Middleton
*St Vincent’s Hospital Melbourne & Australian Catholic University, Australia

Journal of Hospital Infection (2021) 113, 172-179